Skip to content
Inciteful Med

The Biology of PKU: Why Accuracy Matters

Last updated:

A high phenylalanine newborn screen does not always mean classic PKU. In about 2% of cases, it indicates a rare BH4 or DNAJC12 deficiency. Thorough testing is critical because treating these rare deficiencies with only a standard PKU diet can lead to severe neurological damage.

Key Takeaways

  • • High phenylalanine levels can be caused by classic PKU or rare conditions like BH4 and DNAJC12 deficiency.
  • • In classic PKU, the body's PAH enzyme is broken and cannot properly process the amino acid phenylalanine.
  • • Unlike classic PKU, BH4 and DNAJC12 deficiencies also cause a dangerous lack of vital brain chemicals like dopamine and serotonin.
  • • Treating BH4 and DNAJC12 deficiencies with a standard PKU diet alone is dangerous and leads to progressive neurological damage.
  • • Urinary pterin profiling, DHPR activity analysis, and genetic testing are essential to ensure your newborn receives the correct diagnosis and treatment.

When you receive a positive newborn screening for high phenylalanine (Phe), the first assumption is often Phenylketonuria (PKU). However, high Phe levels are actually a “flag” that can represent several different conditions [1]. To ensure the correct treatment, doctors must perform a differential diagnosis—a process of distinguishing between similar conditions—to determine exactly why the Phe is high [2][3].

The Biological Engine: How PAH Works

In a healthy body, the liver uses an enzyme called phenylalanine hydroxylase (PAH) to process the Phe found in protein [4][5]. Think of this enzyme as an engine that converts Phe into another amino acid called tyrosine, which the body needs to make vital brain chemicals [6][7].

For this “engine” to run, it requires two things:

  1. The Engine Itself (PAH): In “classic” PKU, the PAH gene has a mutation, meaning the engine is broken or missing [8][9].
  2. The “Spark Plug” (BH4): The enzyme needs a helper molecule called tetrahydrobiopterin (BH4) to spark the reaction [7][10].
  3. The “Oil” (DNAJC12): A protein called DNAJC12 helps keep the engine folded correctly and stable so it can do its job [11][12].

If any of these three parts fail, Phe cannot be converted to tyrosine. It builds up in the blood and becomes toxic to the brain [4][13].

Why Differential Testing is Critical

While 98% of high Phe cases are due to a broken PAH engine (classic PKU), about 2% are caused by problems with the “spark plug” (BH4 deficiency) or the “oil” (DNAJC12 deficiency) [2][11].

Treating these different conditions with a PKU diet alone is dangerous.

In classic PKU, the only problem is high Phe. In BH4 and DNAJC12 deficiencies, the body also fails to produce critical neurotransmitters like dopamine and serotonin [11][14]. A low-protein diet lowers the Phe, but it does nothing to fix the lack of brain chemicals. If these patients are misdiagnosed and treated only with a diet, they will experience severe, progressive neurological deterioration, including movement disorders (dystonia), seizures, and permanent intellectual disability [2][15][16].

The Essential Testing Battery

To rule out these rare but severe conditions, your medical team must perform the following tests immediately after a positive screen:

  • Urinary Pterin Profiling: This test looks for specific chemicals (neopterin and biopterin) in the urine to see if the body is making BH4 correctly [2][17].
  • DHPR Activity Analysis: A blood test that checks if the body can “recycle” its BH4 spark plugs [2][3].
  • Genetic Testing: Sequencing the PAH, BH4-related genes, and the DNAJC12 gene provides the final, definitive blueprint of the condition [18][12].

When diagnosed correctly, BH4 and DNAJC12 deficiencies are treated with specialized medications—including BH4 supplements and neurotransmitter precursors (like L-dopa)—which can dramatically improve outcomes and prevent brain damage [11][19][20]. Establishing the exact cause of high Phe is the most important step in your child’s early care.

Frequently Asked Questions

Why does my baby have high phenylalanine?
High phenylalanine is most commonly caused by classic Phenylketonuria (PKU), where an enzyme called PAH is missing or broken. However, in about 2% of cases, it is caused by rare conditions like BH4 or DNAJC12 deficiency.
Why is a differential diagnosis important for high phenylalanine?
A differential diagnosis determines exactly why your baby has high phenylalanine. This is critical because rare causes like BH4 deficiency require different treatments, such as specialized medications, to prevent severe brain damage and developmental delays.
Can BH4 and DNAJC12 deficiencies be treated with just a low-protein PKU diet?
No. While a low-protein diet lowers phenylalanine levels, it does not fix the dangerous lack of brain chemicals like dopamine and serotonin associated with these rare deficiencies. Treating them with diet alone can lead to progressive neurological deterioration.
What tests are needed after a positive newborn screen for high phenylalanine?
Your medical team should immediately perform urinary pterin profiling, a DHPR activity blood test, and comprehensive genetic testing. These tests reveal exactly how your child's body processes phenylalanine and identify any specific gene mutations.

Questions for Your Doctor

  • • Have urinary pterin profiling and DHPR activity tests been completed to rule out BH4 deficiency?
  • • If the PAH gene test is negative, will my child be tested for DNAJC12 deficiency?
  • • Can you explain how my child's specific phenylalanine levels on the NBS compare to what you'd expect in BH4 deficiency?
  • • Why is it dangerous to treat these other conditions with a low-protein diet alone?
  • • How soon will we have the results of these differential tests?

Questions for You

  • • Have I noticed any symptoms like poor muscle tone, tremors, or unusual eye movements in my baby that I should report?
  • • Am I clear on why 'PKU' is just one of several reasons blood phenylalanine might be high?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Comprehensive analysis of 1103 infants referred to a single center due to positive newborn screening test for phenylketonuria.

    Kahraman AB, Çıkı K, Poşul B, et al.

    The Turkish journal of pediatrics 2025; (67(2)):175-185 doi:10.24953/turkjpediatr.2025.5263.

    PMID: 40466680
  2. 2

    Four Years of Diagnostic Challenges with Tetrahydrobiopterin Deficiencies in Iranian Patients.

    Khatami S, Dehnabeh SR, Zeinali S, et al.

    JIMD reports 2017; (32()):7-14 doi:10.1007/8904_2016_572.

    PMID: 27246466
  3. 3

    Molecular genetics of phenylketonuria and tetrahydrobiopterin deficiency in Jordan.

    Carducci C, Amayreh W, Ababneh H, et al.

    JIMD reports 2020; (55(1)):59-67 doi:10.1002/jmd2.12130.

    PMID: 32905092
  4. 4

    Genetic etiology and clinical challenges of phenylketonuria.

    Elhawary NA, AlJahdali IA, Abumansour IS, et al.

    Human genomics 2022; (16(1)):22 doi:10.1186/s40246-022-00398-9.

    PMID: 35854334
  5. 5

    PKU dietary handbook to accompany PKU guidelines.

    MacDonald A, van Wegberg AMJ, Ahring K, et al.

    Orphanet journal of rare diseases 2020; (15(1)):171 doi:10.1186/s13023-020-01391-y.

    PMID: 32605583
  6. 6

    Thermodynamics of iron, tetrahydrobiopterin, and phenylalanine binding to phenylalanine hydroxylase from Chromobacterium violaceum.

    Li M, Subedi BP, Fitzpatrick PF, Emerson JP

    Archives of biochemistry and biophysics 2022; (729()):109378 doi:10.1016/j.abb.2022.109378.

    PMID: 35995215
  7. 7

    Biochemical and biophysical approaches to characterization of the aromatic amino acid hydroxylases.

    Fitzpatrick PF, Daubner SC

    Methods in enzymology 2024; (704()):345-361 doi:10.1016/bs.mie.2024.05.009.

    PMID: 39300655
  8. 8

    The phenylketonuria-associated substitution R68S converts phenylalanine hydroxylase to a constitutively active enzyme but reduces its stability.

    Khan CA, Meisburger SP, Ando N, Fitzpatrick PF

    The Journal of biological chemistry 2019; (294(12)):4359-4367 doi:10.1074/jbc.RA118.006477.

    PMID: 30674554
  9. 9

    The Pah-R261Q mouse reveals oxidative stress associated with amyloid-like hepatic aggregation of mutant phenylalanine hydroxylase.

    Aubi O, Prestegård KS, Jung-Kc K, et al.

    Nature communications 2021; (12(1)):2073 doi:10.1038/s41467-021-22107-1.

    PMID: 33824313
  10. 10

    The aromatic amino acid hydroxylases: Structures, catalysis, and regulation of phenylalanine hydroxylase, tyrosine hydroxylase, and tryptophan hydroxylase.

    Fitzpatrick PF

    Archives of biochemistry and biophysics 2023; (735()):109518 doi:10.1016/j.abb.2023.109518.

    PMID: 36639008
  11. 11

    Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability.

    Anikster Y, Haack TB, Vilboux T, et al.

    American journal of human genetics 2017; (100(2)):257-266 doi:10.1016/j.ajhg.2017.01.002.

    PMID: 28132689
  12. 12

    DNACJ12 deficiency in patients with unexplained hyperphenylalaninemia: two new patients and a novel variant.

    Çıkı K, Yıldız Y, Yücel Yılmaz D, et al.

    Metabolic brain disease 2021; (36(6)):1405-1410 doi:10.1007/s11011-021-00753-0.

    PMID: 34014443
  13. 13

    AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria.

    Richards DY, Winn SR, Dudley S, et al.

    Molecular therapy. Methods & clinical development 2020; (17()):234-245 doi:10.1016/j.omtm.2019.12.004.

    PMID: 31970201
  14. 14

    Massive parallel sequencing as a new diagnostic approach for phenylketonuria and tetrahydrobiopterin-deficiency in Thailand.

    Chaiyasap P, Ittiwut C, Srichomthong C, et al.

    BMC medical genetics 2017; (18(1)):102 doi:10.1186/s12881-017-0464-x.

    PMID: 28915855
  15. 15

    DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias.

    Blau N, Martinez A, Hoffmann GF, Thöny B

    Molecular genetics and metabolism 2018; (123(1)):1-5 doi:10.1016/j.ymgme.2017.11.005.

    PMID: 29174366
  16. 16

    Tetrahydrobiopterin deficiencies: Lesson from clinical experience.

    Bozaci AE, Er E, Yazici H, et al.

    JIMD reports 2021; (59(1)):42-51 doi:10.1002/jmd2.12199.

    PMID: 33977029
  17. 17

    Gene mutation and pedigree analysis of tetrahydrobiopterin deficiency in a Uygur family of China.

    Li L, Qin Y, Su Y, et al.

    Journal of clinical laboratory analysis 2019; (33(2)):e22665 doi:10.1002/jcla.22665.

    PMID: 30221392
  18. 18

    Genotypic variants of the tetrahydrobiopterin (BH4) biosynthesis genes in patients with hyperphenylalaninemia from different regions of Iran.

    Nezhad SRK, Aligoodarzi PN, Rostami G, et al.

    Molecular genetics & genomic medicine 2024; (12(1)):e2294 doi:10.1002/mgg3.2294.

    PMID: 37818795
  19. 19

    The treatment and clinical follow-up outcome in Iranian patients with tetrahydrobiopterin deficiency.

    Khani S, Barzegari M, Esmaeilizadeh Z, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2021; (34(9)):1157-1167 doi:10.1515/jpem-2021-0155.

    PMID: 34214291
  20. 20

    Neurotransmitters Disorders with Mild Hyperphenylalaninemia: The Ones That Should Not Be Missed.

    Thoalnoon OA, Kareem AA, Hammoodi HZ

    Archives of Razi Institute 2023; (78(2)):667-673 doi:10.22092/ARI.2022.359480.2431.

    PMID: 37396747

This page explains the biology and differential diagnosis of high phenylalanine for educational purposes. Always consult a pediatric metabolic specialist or geneticist to interpret your child's specific newborn screening results.

Stay up to date

Get notified when new research about Phenylketonuria is published.

No spam. Unsubscribe anytime.